Sulfair 10

ANDA 88000, held by Pharmafair. Sulfacetamide Sodium.

As of Nov 15, 2026, ANDA 88000 (Sulfair 10), held by Pharmafair, was first approved by FDA on Dec 22, 1982, with 1 approved supplement and 0 published complete response letters.

First approved: Dec 22, 1982
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
Dec 22, 1982	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Sulfair 1010% · ointment;ophthalmic	Sulfacetamide Sodium	Discontinued

All 2 submissions, including labeling and manufacturing supplements


Jul 14, 1988	Supplement 6Labeling	Approved	None posted
Dec 22, 1982	Original application	Approved	None posted

Identifiers

Application: ANDA 88000
Drugs@FDA: Overview at FDA
Company: Pharmafair

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters